ViewRay, Inc. (VRAY): Price and Financial Metrics


ViewRay, Inc. (VRAY)

Today's Latest Price: $2.97 USD

0.04 (-1.33%)

Updated Oct 30 4:00pm

Add VRAY to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

VRAY Stock Summary

  • ViewRay Inc's stock had its IPO on April 1, 2016, making it an older stock than merely 16.1% of US equities in our set.
  • As for revenue growth, note that VRAY's revenue has grown -25.88% over the past 12 months; that beats the revenue growth of just 11% of US companies in our set.
  • ViewRay Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -33.95%, greater than the shareholder yield of just 12.27% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ViewRay Inc, a group of peers worth examining would be CASI, CYBR, VERI, NEWR, and EVBG.
  • Visit VRAY's SEC page to see the company's official filings. To visit the company's web site, go to www.viewray.com.

VRAY Stock Price Chart Interactive Chart >

Price chart for VRAY

VRAY Price/Volume Stats

Current price $2.97 52-week high $4.88
Prev. close $3.01 52-week low $1.11
Day low $2.89 Volume 583,800
Day high $3.02 Avg. volume 1,716,179
50-day MA $3.04 Dividend yield N/A
200-day MA $2.60 Market Cap 439.40M

ViewRay, Inc. (VRAY) Company Bio


ViewRay, Inc. designs, manufactures, and markets radiation therapy systems worldwide. It offers MRIdian, a MRI-guided radiation therapy system that images and treats cancer patients simultaneously. MRIdian integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. The company markets its MRIdian through a direct sales force in the United States and distributors worldwide to a range of customers, including university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. was founded in 2004 and is based in Oakwood Village, Ohio.


VRAY Latest News Stream


Event/Time News Detail
Loading, please wait...

VRAY Latest Social Stream


Loading social stream, please wait...

View Full VRAY Social Stream

Latest VRAY News From Around the Web

Below are the latest news stories about ViewRay Inc that investors may wish to consider to help them evaluate VRAY as an investment opportunity.

Chungnam National University Sejong Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

CLEVELAND, Sept. 24, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Chungnam National University Sejong Hospital in Sejong, South Korea has begun patient treatments with the MRIdian® MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines…

PR Newswire | September 24, 2020

10,000th Patient Receives Treatment with ViewRay's MRIdian System

CLEVELAND, Sept. 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that 10,000 patients have been treated to date using the company's MRIdian® MRI-Guided Radiation Therapy System, the world's first system to combine MR imaging with radiation delivery. Unlike…

PR Newswire | September 1, 2020

ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer

CLEVELAND, Aug. 27, 2020 /PRNewswire/ --– ViewRay, Inc. (Nasdaq: VRAY) announced today that the GenesisCare Foundation's Compassionate Access Programme is now accepting patients for treatment on the MRIdian® MRI-Guided Radiation Therapy System. The program, in collaboration with the…

PR Newswire | August 27, 2020

Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

CLEVELAND, Aug. 5, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the MRIdian® MR-Guided Radiation Therapy System, a cutting-edge device that…

PR Newswire | August 5, 2020

ViewRay's (VRAY) CEO Scott Drake on Q2 2020 Results - Earnings Call Transcript

ViewRay, Inc. (VRAY) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET Company Participants Michaella Gallina – Vice President-Chief of Staff and Head-Investor Relations Scott Drake – President and Chief Executive Officer Zach Stassen – Chief Financial Officer Shahriar Matin – Chief Operating Officer Conference Call Participants Anthony...

SA Transcripts on Seeking Alpha | August 1, 2020

Read More 'VRAY' Stories Here

VRAY Price Returns

1-mo -15.14%
3-mo 7.22%
6-mo 56.32%
1-year 14.23%
3-year -56.89%
5-year -34.00%
YTD -29.62%
2019 -30.48%
2018 -34.45%
2017 195.85%
2016 -43.09%
2015 N/A

Continue Researching VRAY

Here are a few links from around the web to help you further your research on ViewRay Inc's stock as an investment opportunity:

ViewRay Inc (VRAY) Stock Price | Nasdaq
ViewRay Inc (VRAY) Stock Quote, History and News - Yahoo Finance
ViewRay Inc (VRAY) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7424 seconds.